| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | XTANT MED HLDGS INC | 475,439 | 261,000 | 0.00% | ||
| 2 | ALIMERA SCIENCES INC | 250,000 | 270,000 | 0.00% | ||
| 3 | ARALEZ PHARMACEUTICALS INC | 68,143 | 301,000 | 0.00% | ||
| 4 | MEDIGUS LTD | 600,000 | 339,000 | 0.00% | ||
| 5 | BIOMARIN PHARMACEUTICAL INC 0.75 10/15/2018 | 500,000 | 562,000 | 0.01% | PRN | |
| 6 | Marinus Pharmaceuticals Inc | 567,600 | 573,000 | 0.01% | ||
| 7 | BIOMARIN PHARMACEUTICAL INC SR SB CONV NT 20 | 500,000 | 589,000 | 0.01% | PRN | |
| 8 | NOVELION THERAPEUTICS INC | 100,000 | 842,000 | 0.01% | ||
| 9 | BIOLINERX LTD | 1,038,600 | 956,000 | 0.01% | ||
| 10 | AMARIN CORP PLC | 350,000 | 1,078,000 | 0.01% | ||
| 11 | OREXIGEN THERAPEUTICS INC | 5,210,000 | 1,465,000 | 0.02% | PRN | |
| 12 | SANGAMO THERAPEUTICS INCORPORATED | 707,400 | 2,158,000 | 0.03% | ||
| 13 | PTC THERAPEUTICS INC | 204,400 | 2,230,000 | 0.03% | ||
| 14 | CLEARSIDE BIOMEDICAL INC | 300,000 | 2,682,000 | 0.03% | ||
| 15 | VALEANT PHARMACEUTICALS INTL | 194,900 | 2,830,000 | 0.04% | ||
| 16 | ADAPTIMMUNE THERAPEUTICS PLC | 724,184 | 2,933,000 | 0.04% | ||
| 17 | AMEDISYS INC COM | 71,500 | 3,048,000 | 0.04% | ||
| 18 | INVITAE CORP | 456,666 | 3,626,000 | 0.05% | ||
| 19 | ROKA BIOSCIENCE INC COM NEW | 893,470 | 3,788,000 | 0.05% | ||
| 20 | INFINITY PHARMACEUTICALS INC | 3,250,300 | 4,388,000 | 0.06% | ||
| 21 | ZIMMER BIOMET HLDGS INC | 49,000 | 5,057,000 | 0.06% | ||
| 22 | Syndax Pharmaceuticals Inc | 757,365 | 5,430,000 | 0.07% | ||
| 23 | REDHILL BIOPHARMA LTD | 564,900 | 5,909,000 | 0.08% | ||
| 24 | AEGLEA BIOTHERAPEUTICS INC | 1,360,224 | 5,917,000 | 0.08% | ||
| 25 | CELLECTIS S A | 350,000 | 5,933,000 | 0.08% | ||
| 26 | AEGERION PHARMACEUTICALS INC | 8,000,000 | 5,976,000 | 0.08% | PRN | |
| 27 | AFFIMED N V COM | 3,375,000 | 6,075,000 | 0.08% | ||
| 28 | SIENTRA INC | 742,574 | 6,327,000 | 0.08% | ||
| 29 | TESARO INCORPORATED | 47,200 | 6,347,000 | 0.08% | ||
| 30 | MINERVA NEUROSCIENCES INC COM | 556,200 | 6,535,000 | 0.08% | ||
| 31 | FLUIDIGM CORP DEL | 10,000,000 | 7,013,000 | 0.09% | PRN | |
| 32 | INOTEK PHARMACEUTICALS CORP | 7,000,000 | 7,354,000 | 0.09% | PRN | |
| 33 | CRISPR THERAPEUTICS AG | 372,191 | 7,541,000 | 0.10% | ||
| 34 | XENON PHARMACEUTICALS INC | 1,000,000 | 7,700,000 | 0.10% | ||
| 35 | STEADYMED LTD | 3,072,196 | 7,988,000 | 0.10% | ||
| 36 | NUVASIVE INC | 123,500 | 8,319,000 | 0.11% | ||
| 37 | INCYTE CORP SR CV NT0.375 18 | 4,250,000 | 8,496,000 | 0.11% | PRN | |
| 38 | INCYTE CORP | 4,250,000 | 8,670,000 | 0.11% | PRN | |
| 39 | ABBOTT LABS | 245,400 | 9,426,000 | 0.12% | ||
| 40 | ADR - Nabriva Therapeutics AG- Usd | 1,677,940 | 10,001,000 | 0.13% | ||
| 41 | Pieris Pharmaceuticals | 7,259,620 | 10,201,000 | 0.13% | ||
| 42 | SELECT MED HLDGS CORP COM | 831,900 | 11,023,000 | 0.14% | ||
| 43 | LILLY ELI & CO | 150,000 | 11,033,000 | 0.14% | Call | |
| 44 | INOTEK PHARMACEUTICALS CORP | 1,849,300 | 11,281,000 | 0.14% | ||
| 45 | ProQR Therapeutics NV | 2,305,446 | 11,297,000 | 0.14% | ||
| 46 | ULTRAGENYX PHARMACEUTICAL INC COM | 169,300 | 11,903,000 | 0.15% | ||
| 47 | VANDA PHARMACEUTICALS INC COM | 750,000 | 11,963,000 | 0.15% | Call | |
| 48 | FORWARD PHARMA A/S | 798,000 | 11,970,000 | 0.15% | ||
| 49 | DBV TECHNOLOGIES S A | 345,700 | 12,144,000 | 0.15% | ||
| 50 | ALEXION PHARMACEUTIC | 100,000 | 12,235,000 | 0.16% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-17-000766, filed 2017.02.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
